Aimmune Therapeutics Inc. (AIMT) Fell -5.7% or -1.82 To Price $30.11 On Thursday


Aimmune Therapeutics Inc. (AIMT) fell -5.7% or -1.82 to $30.11. It is near to 881449 shares traded, which is 57.8% compare to the average total volume 1.52 million. The market cap of AIMT is $1.74 billion. The year to date change is -14.6%. The 52 week price range is from $15.97 to $42.0. Price of AIMT have changed -1.15% during last week. It have changed -0.87% over last month, -14.81% over last 3 months, 33.60% over last 6 months and 45.27% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AIMT is 35.46. It is 17.77% above current price. The 200-day Moving Averages for AIMT is 28.45. It is -5.51% below current price. The 52-week High is 42.0. It is 39.49% from the current price. The 52-week Low is 15.97. It is -46.96% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AIMT is 2.62 on 2018-02-28. Short % to float is 6.69%. There are some statistics of AIMT. It is has market cap $1.74 billion. The share outstanding is 57.85 million. The average volume is 1.52 million. The percent of top 15 Institution holding is 62.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AIMT is -56.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AIMT is -51.94%.


Tags:

Share this post